Daoussis, Dimitrios <br/><br/>
B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin.  [electronic resource] 

 -  Arthritis research & therapy  Jun 2012 
 - R145 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/ar3879  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>B-Lymphocytes--drug effects<br/>Female<br/>Fibrosis<br/>Humans<br/>Immunohistochemistry<br/>Lymphocyte Depletion--methods<br/>Male<br/>Middle Aged<br/>Receptor, Platelet-Derived Growth Factor alpha--biosynthesis<br/>Receptor, Platelet-Derived Growth Factor beta--biosynthesis<br/>Receptors, Platelet-Derived Growth Factor--metabolism<br/>Rituximab<br/>Scleroderma, Diffuse--drug therapy<br/>Skin--metabolism